RPS15 and esophageal squamous cell carcinoma: Functional assays indicated that SB203580 treatment alone inhibited ESCC cell proliferation and metastasis to a moderate degree, whereas by combining SB203580 and DDP, the proliferation of RPS15-overexpressing ESCC cells was inhibited compared with that in the control cells.